Search

everythinglearnresearchcommunity

for

Search:↓

The normal human prostate does not significantly affect blood DHT levels.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Hormonal imbalances are a key cause of missed menstrual periods in women.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Flutamide reduces hair growth better but has more side effects.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.